Who is sponsoring NCT04639544?

NCT04639544 is sponsored by Biosearch S.A..

What condition does NCT04639544 study?

NCT04639544 studies Recurrent Vulvovaginal Candidiasis.

What drugs are being tested in NCT04639544?

Interventions: Placebo, Lactobacillus strain.

What is the status of NCT04639544?

NCT04639544 is currently UNKNOWN.

Last reviewed 2021-01-22 · How we verify

Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal Candidiasis

NCT04639544 NA UNKNOWN

The objective of this study is to evaluate the efficacy of the consumption of the one probiotic strain in the prevention of new vaginal candidiasis events in women with recurrent vaginal candidiasis. This is a preliminary study whose purpose is to know if this probiotic is effective in reducing the number of candidiasis events and / or increasing the time between possible relapses in women diagnosed with RVVC.

Details

Lead sponsor	Biosearch S.A.
Phase	NA
Status	UNKNOWN
Enrolment	76
Start date	Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Recurrent Vulvovaginal Candidiasis

Interventions

Placebo
Lactobacillus strain

Countries

Spain